HSIC vs QGEN
Henry Schein vs Qiagen N.V. — AI-powered side-by-side comparison
| Metric | HSIC | QGEN |
|---|
| AI Score |
67
|
64
|
| Price |
$89.16
|
$42.66
|
| P/E Ratio |
25.77×
|
21.87×
|
| ROE |
12.3%
|
11.2%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
30.3%
|
61.7%
|
| Debt / Equity |
1.21×
|
0.49×
|
| Dividend Yield |
0.0%
|
6.2%
|
| RSI (14) |
59.4
|
57.5
|
| Beta |
0.808
|
0.62
|
| Expected Upside |
+0.8%
|
—
|
AI Committee View
Current Innellis committee reasoning for HSIC versus QGEN.
HSIC leads by 3 points.
HSIC scores 67/100 (Buy) versus QGEN at 64/100 (Buy).
HSIC Committee View
75% agreement
4 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
QGEN Committee View
80% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- EPS growing 341.4% YoY — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro